Inicio/Compuestos/Intermediario farmacéutico/Ethyl (4R)-4-[(3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
C28H46O4
446.7 g/mol
Intermediario farmacéuticoAtención
Ethyl (4R)-4-[(3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
CAS459789-97-0EC815-635-6
Categoría
Intermediario farmacéutico
Clase de Compuesto
Esteroide
Uso Principal
Intermediario farmacéutico
This compound is a steroidal pharmaceutical intermediate characterized by a tetracyclic ring system and multiple chiral centers. Its primary significance lies in its use as a building block for the synthesis of specialized steroid derivatives.
pharmaceutical intermediateraw material for steroid derivative synthesis
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 459789-97-0
Compuestos relacionados
SimilarEstructura similarSimilitud 0.80
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
CAS915038-26-5
active pharmaceutical ingredient
SimilarEstructura similarSimilitud 0.80
(R)-4-((3R,5S,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
CAS1892540-33-8
active pharmaceutical ingredient
ReferenciaMisma categoría
6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINE
CAS4602-83-9
pharmaceutical intermediate
ReferenciaMisma categoría
(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
CAS46022-05-3
Pharmaceutical intermediate for lurasidone
ReferenciaMisma categoría
3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (10-phenylanthracen-9-yl)boronate
CAS460347-59-5
synthetic intermediate for boron-containing compounds
ReferenciaMisma categoría
1,1,1-Trifluoro-4-iodobutane
CAS461-17-6
Pharmaceutical intermediate
Referenciasame scaffold
3alpha-Hydroxy-7-oxo-5beta-cholan-24-oic acid methyl ester
CAS10538-59-7
bile acid intermediate for drug synthesis
Referenciasame scaffold
7-Ketolithocholic acid
CAS4651-67-6
bile acid intermediate
Referencia de Seguridad
Atención
H373May cause damage to organs through prolonged or repeated exposure
Identificadores
Nombre IUPAC
ethyl (4R)-4-[(3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
InChIKey
PRZCLWHVOYRZJL-GAKWKJAJSA-N
SMILES
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C1=O)CC[C@@H]4[C@H](C)CCC(=O)OCC)C)C)O
Sinónimos (3)
—